Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (21-30 of 1,153) with videos related to

Pageof 116
Sort By:
The American Journal of Cardiology|March 1, 2000
A symposium: lipid management summit on improving practice outcome. IntroductionC M Ballantyne
American Heart Journal|June 24, 2004
Achieving greater reductions in cardiovascular risk: lessons from statin therapy on risk measures and risk reductionChristie M Ballantyne
Texas Heart Institute Journal|January 6, 2006
Cholesterol, lipids, and statinsChristie M Ballantyne
Hospitals & Health Networks|August 20, 1995
A man for the people. Interview by Kevin LumsdonR M Ballantyne
JACC. Heart Failure|January 8, 2016
Lipoprotein(a) and Heart Failure: Another Reason to Study Interventions in Patients With Very High Levels of Lipoprotein(a)?Christie M Ballantyne
Current Atherosclerosis Reports|December 10, 2003
Role of selective cholesterol absorption inhibition in the management of dyslipidemiaChristie M Ballantyne
The American Journal of Cardiology|February 17, 2001
Case 4: type 2 diabetes, hypertension, and dyslipidemiaC M Ballantyne
Clinical Cardiology|July 11, 2001
Treating mixed dyslipidemias: why and howC M Ballantyne
Lancet (London, England)|February 21, 2002
Soluble adhesion molecules and coronary heart diseaseChristie M Ballantyne
Applied Optics|January 9, 2010
Double beam operation of a Fourier spectrometerJ M Ballantyne
Pageof 116

Showing results (21-30 of 1,153) with videos related to

Sort By:
Pageof 116
The American Journal of Cardiology|March 1, 2000
A symposium: lipid management summit on improving practice outcome. IntroductionC M Ballantyne
American Heart Journal|June 24, 2004
Achieving greater reductions in cardiovascular risk: lessons from statin therapy on risk measures and risk reductionChristie M Ballantyne
Texas Heart Institute Journal|January 6, 2006
Cholesterol, lipids, and statinsChristie M Ballantyne
Hospitals & Health Networks|August 20, 1995
A man for the people. Interview by Kevin LumsdonR M Ballantyne
JACC. Heart Failure|January 8, 2016
Lipoprotein(a) and Heart Failure: Another Reason to Study Interventions in Patients With Very High Levels of Lipoprotein(a)?Christie M Ballantyne
Current Atherosclerosis Reports|December 10, 2003
Role of selective cholesterol absorption inhibition in the management of dyslipidemiaChristie M Ballantyne
The American Journal of Cardiology|February 17, 2001
Case 4: type 2 diabetes, hypertension, and dyslipidemiaC M Ballantyne
Clinical Cardiology|July 11, 2001
Treating mixed dyslipidemias: why and howC M Ballantyne
Lancet (London, England)|February 21, 2002
Soluble adhesion molecules and coronary heart diseaseChristie M Ballantyne
Applied Optics|January 9, 2010
Double beam operation of a Fourier spectrometerJ M Ballantyne
Pageof 116